PHOSPHO-TRIN 250 NEUTRAL- sodium phosphate, dibasic, anhydrous, potassium phosphate, monobasic, and sodium phosphate, monobasic,

Страна: США

мова: англійська

Джерело: NLM (National Library of Medicine)

Активний інгредієнт:

SODIUM PHOSPHATE, DIBASIC, ANHYDROUS (UNII: 22ADO53M6F) (PHOSPHATE ION - UNII:NK08V8K8HR), POTASSIUM PHOSPHATE, MONOBASIC (UNII: 4J9FJ0HL51) (PHOSPHATE ION - UNII:NK08V8K8HR), SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE (UNII: 593YOG76RN) (PHOSPHATE ION - UNII:NK08V8K8HR)

Доступна з:

Patrin Pharma, Inc.

ІПН (Міжнародна Ім'я):

SODIUM PHOSPHATE, DIBASIC, ANHYDROUS

Склад:

SODIUM PHOSPHATE, DIBASIC, ANHYDROUS 852 mg

Адміністрація маршрут:

ORAL

Терапевтичні свідчення:

Phospho-Trin™ 250 Neutral increases urinary phosphate and pyrophosphate. As a phosphorus supplement, each tablet supplies 25% of the U.S. Recommended Daily Allowance (U.S. RDA) of phosphorus for adults and children over 4 years of age. This product is contraindicated in patients with infected phosphate stones, in patients with severely impaired renal function (less than 30% of normal) and in the presence of hyperphosphatemia.

Огляд продуктів:

White, oval-shaped tablet, debossed with P107 on each tablet. NDC #39328-107-10 Bottles of 100 tablets Keep tightly closed. Store upright at 20 to 25°C (68 to 77°F). Excursions permitted 15 to 30°C (59 to 86°F) [see USP Controlled Room Temperature]. Keep out of reach of children. Dispense in tight, light-resistant containers with child resistant closures.

Статус Авторизація:

MEDICAL FOOD

Характеристики продукта

PHOSPHO-TRIN 250 NEUTRAL- SODIUM PHOSPHATE, DIBASIC, ANHYDROUS,
POTASSIUM
PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
TABLET
PATRIN PHARMA, INC.
----------
PHOSPHO-TRIN™ 250 NEUTRAL
PHOSPHORUS SUPPLEMENT
250 MG PER TABLET
DESCRIPTION
Each tablet contains 852 mg dibasic sodium phosphate anhydrous, 155 mg
monobasic potassium
phosphate, and 130 mg monobasic sodium phosphate monohydrate. Each
tablet yields approximately 250
mg of phosphorus, 298 mg of sodium (13.0 mEq) and 45 mg of potassium
(1 .1 mEq).
OTHER INGREDIENTS
Cellulose, Pregelatinized Starch, Magnesium Stearate, Silicon Dioxide
and Natural Flavor
CLINICAL PHARMACOLOGY
Phosphorus has a number of important functions in the biochemistry of
the body. The bulk of the body's
phosphorus is located in the bones, where it plays a key role in
osteoblastic and osteoclastic activities.
Enzymatically catalyzed phosphate-transfer reactions are numerous and
vital in the metabolism of
carbohydrate, lipid and protein, and a proper concentration of the
anion is of primary importance in
assuring an orderly biochemical sequence. ln addition, phosphorus
plays an important role in modifying
steady-state tissue concentrations of calcium. Phosphate ions are
important buffers of the intracellular
fluid, and also play a primary role in the renal excretion of the
hydrogen ion.
Oral administration of inorganic phosphates increases serum phosphate
levels. Phosphates lower
urinary calcium levels in idiopathic hypercalciuria.
In general, in adults, about two thirds of the ingested phosphate in
absorbed from the bowel, most of
which is rapidly excreted into the urine.
INDICATIONS AND USAGE
Phospho-Trin™ 250 Neutral increases urinary phosphate and
pyrophosphate. As a phosphorus
supplement, each tablet supplies 25% of the U.S. Recommended Daily
Allowance (U.S. RDA) of
phosphorus for adults and children over 4 years of age.
CONTRAINDICATIONS
This product is contraindicated in patients with infected phosphate
stones, in patients with severely
impaired renal functi